Inositol Requiring Enzyme 1α Mediates Hypertension and Vascular Remodeling.
Keiichi Torimoto; Yuki Nakayama; Yuka Terada; Keisuke Okuno; Stephanie Cicalese; Brooke Mangano; Tomoko Akiyama; Yayoi Kimura; Hirotoshi Utsunomiya; Tomoki Hashimoto; Jin O-Uchi; Patrick Osei-Owusu; Satoru Eguchi
Hypertension (Dallas, Tex. : 1979), Mar. 2026

Effectiveness of evocalcet for hypercalcemia in patients with primary hyperparathyroidism.
Kenichi Tanaka; Yosuke Okada; Kenji Koikawa; Fumi Uemura; Maiko Sumikawa; Keiichi Torimoto; Yoshiya Tanaka
Endocrine journal, Aug. 2025

Association of Glycaemia Risk Index With Indices of Atherosclerosis: A Cross-Sectional Study.
Keiichi Torimoto; Yosuke Okada; Tomoya Mita; Kenichi Tanaka; Fumiya Sato; Naoto Katakami; Hidenori Yoshii; Keiko Nishida; Yoshiya Tanaka; Ryota Ishii; Masahiko Gosho; Iichiro Shimomura; Hirotaka Watada
Journal of diabetes, Mar. 2025

Cardiac and perivascular myofibroblasts, matrifibrocytes, and immune fibrocytes in hypertension; commonalities and differences with other cardiovascular diseases.
Keiichi Torimoto; Katherine Elliott; Yuki Nakayama; Hiromi Yanagisawa; Satoru Eguchi
Cardiovascular research, May 2024

Milestone Papers on Signal Transduction Mechanisms of Hypertension and Its Complications.
Satoru Eguchi; Keiichi Torimoto; Adebowale Adebiyi; Praghalathan Kanthakumar; Gisele F Bomfim; Camilla Ferreira Wenceslau; Shelby A Dahlen; Patrick Osei-Owusu
Hypertension (Dallas, Tex. : 1979), May 2024

Mitochondrial fission inhibition protects against hypertension induced by angiotensin II.
Kyle J Preston; Tatsuo Kawai; Keiichi Torimoto; Ryohei Kuroda; Yuki Nakayama; Tomoko Akiyama; Yayoi Kimura; Rosario Scalia; Michael V Autieri; Victor Rizzo; Tomoki Hashimoto; Patrick Osei-Owusu; Satoru Eguchi
Hypertension research : official journal of the Japanese Society of Hypertension, May 2024

Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial
Atsushi Tanaka; Michio Shimabukuro; Hiroki Teragawa; Hisako Yoshida; Yosuke Okada; Toshinari Takamura; Isao Taguchi; Shigeru Toyoda; Hirofumi Tomiyama; Shinichiro Ueda; Yukihito Higashi; Koichi Node; Junya Ako; Hirohisa Amano; Itaru Hisauchi; Yumi Ikehara; Hideaki Jinnouchi; Yoshiyuki Kawano; Kazuo Kimura; Akira Kurozumi; Takaaki Kusumoto; Noritaka Machii; Tatsuya Maruhashi; Yasushi Matsuzawa; Hirofumi Misu; Manabu Narisawa; Tsuguhito Ota; Jun Ichi Oyama; Masashi Sakuma; Kazuki Shiina; Kosuke R. Shima; Seigo Sugiyama; Kunihiro Suzuki; Naohiko Takahashi; Yasuhiko Takemoto; Yumie Takeshita; Hiroshi Tamaki; Kenichi Tanaka; Akira Tamura; Keiichi Torimoto; Minako Yamaoka-Tojo; Hiroki Uehara; Fumi Uemura; Ken Yamakawa; Kunio Yufu
Hypertension Research, 2024

Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial
Naoto Katakami; Tomoya Mita; Hidenori Yoshii; Toshihiko Shiraiwa; Tetsuyuki Yasuda; Yosuke Okada; Akira Kurozumi; Masahiro Hatazaki; Hideaki Kaneto; Takeshi Osonoi; Tsunehiko Yamamoto; Nobuichi Kuribayashi; Kazuhisa Maeda; Hiroki Yokoyama; Keisuke Kosugi; Kentaro Ohtoshi; Isao Hayashi; Satoru Sumitani; Mamiko Tsugawa; Kayoko Ryomoto; Ken Kato; Tadashi Nakamura; Satoshi Kawashima; Yasunori Sato; Hirotaka Watada; Iichiro Shimomura; K. Komiyama; T. Shimizu; S. Kamei; T. Kinoshita; M. Shimoda; M. Saito; N. Fujiki; Y. Fujita; S. Shimizu; Y. Umayahara; Y. Irie; R. Kataoka; Y. Kiyohara; M. Ohashi; Kayoko Ryomoto; Y. Takahi; Y. Fujishima; Y. Fujita; A. Fukuhara; K. Fukui; Y. Hosokawa; A. Imagawa; H. Iwahashi; K. Mukai; T. Katsura; D. Kawamori; T. Kimura; S. Kobayashi; J. Kozawa; F. Kubo; N. Maeda; T. Matsuoka; K. Miyashita; S. Nakata; H. Ninomiya; H. Nishizawa; Y. Okuno; M. Otsuki; F. Sakamoto; S. Sasaki; I. Sato; N. Shimo; I. Shimomura; M. Takahara; T. Takano; A. Tokunaga; S. Uno; M. Yamaoka; S. Yoneda; M. Hajime; K. Koikawa; F. Kuno; K. Matsushita; M. Narisawa; K. Tanaka; K. Sugai; K. Torimoto
Cardiovascular Diabetology, Dec. 2023

Infused juice concentrate of Japanese plum Prunus mume attenuates inflammatory vascular remodeling in a mouse model of hypertension induced by angiotensin II.
Keisuke Okuno; Keiichi Torimoto; Ryohei Kuroda; Stephanie M Cicalese; Yoshiharu Okuno; Ryohei Kono; Shinsuke Marumoto; Hirotoshi Utsunomiya; Satoru Eguchi
Hypertension research : official journal of the Japanese Society of Hypertension, Aug. 2023

Effect of ipragliflozin on endothelial dysfunction in patients with type 2 diabetes and chronic kidney disease: A randomized clinical trial (PROCEED).
Atsushi Tanaka; Yosuke Okada; Keiichi Torimoto; Nozomu Kamei; Hiroyuki Hirai; Teruyuki Kono; Kazuhiro Sugimoto; Hiroki Teragawa; Isao Taguchi; Tatsuya Maruhashi; Satomi Sonoda; Akira Kurozumi; Saori Inagaki; Chikage Oshita; Itaru Hisauchi; Kanae Takahashi; Yukihito Higashi; Michio Shimabukuro; Koichi Node
Diabetes & metabolism, Jul. 2023

Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II.
Keisuke Okuno; Keiichi Torimoto; Stephanie M Cicalese; Kyle Preston; Victor Rizzo; Tomoki Hashimoto; Thomas M Coffman; Matthew A Sparks; Satoru Eguchi
Hypertension (Dallas, Tex. : 1979), Mar. 2023

Smooth muscle angiotensin II type 1A receptor is required for abdominal aortic aneurysm formation induced by angiotensin II plus β-aminopropionitrile.
Keisuke Okuno; Keiichi Torimoto; Stephanie M Cicalese; Tomoki Hashimoto; Matthew A Sparks; Victor Rizzo; Satoru Eguchi
Journal of molecular and cellular cardiology, Mar. 2023

Endoplasmic Reticulum Chemical Chaperone 3-Hydroxy-2-Naphthoic Acid Reduces Angiotensin II-Induced Vascular Remodeling and Hypertension In Vivo and Protein Synthesis In Vitro.
Stephanie Cicalese; Keiichi Torimoto; Keisuke Okuno; Katherine J Elliott; Victor Rizzo; Tomoki Hashimoto; Satoru Eguchi
Journal of the American Heart Association, Dec. 2022

Association Between Time in Range and Postprandial Glucose Contribution Rate in Non-Insulin-Treated Type 2 Diabetes Patients: Inverse Correlation of Time in Range with Postprandial Glucose Contribution Rate.
Fumi Uemura; Yosuke Okada; Keiichi Torimoto; Yoshiya Tanaka
Diabetes technology & therapeutics, Nov. 2022

Comprehensive immunophenotypic analysis reveals the pathological involvement of Th17 cells in Graves' disease.
Keiichi Torimoto; Yosuke Okada; Shingo Nakayamada; Satoshi Kubo; Akira Kurozumi; Manabu Narisawa; Yoshiya Tanaka
Scientific reports, Oct. 2022

An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus.
Maiko Hajime Sumikawa; Shigeru Iwata; Mingzeng Zhang; Hiroko Miyata; Masanobu Ueno; Yasuyuki Todoroki; Atsushi Nagayasu; Ryuichiro Kanda; Koshiro Sonomoto; Keiichi Torimoto; Seunghyun Lee; Shingo Nakayamada; Kazuo Yamamoto; Yosuke Okada; Yoshiya Tanaka
Rheumatology (Oxford, England), Jul. 2022

Blood glucose dynamics during sleep in patients with obstructive sleep apnea and normal glucose tolerance: effects of CPAP therapy.
Kimimasa Saito; Yosuke Okada; Keiichi Torimoto; Yoko Takamatsu; Yoshiya Tanaka
Sleep & breathing = Schlaf & Atmung, Jun. 2022

Risk Factor Analysis for Type 2 Diabetes Patients About Hypoglycemia Using Continuous Glucose Monitoring: Results from a Prospective Observational Study.
Fumi Uemura; Yosuke Okada; Tomoya Mita; Keiichi Torimoto; Satomi Wakasugi; Naoto Katakami; Hidenori Yoshii; Koji Matsushita; Keiko Nishida; Nobuo Inokuchi; Yoshiya Tanaka; Masahiko Gosho; Iichiro Shimomura; Hirotaka Watada
Diabetes technology & therapeutics, Jun. 2022

Hypoglycemia induces vascular endothelial dysfunction in subjects with normal glucose tolerance.
Kenichi Tanaka; Yosuke Okada; Keiichi Torimoto; Kosuke Nishio; Manabu Narisawa; Yoshiya Tanaka
Scientific reports, Feb. 2022

Relationship between blood glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics: Subanalysis of a prospective cohort study.
Akemi Tokutsu; Yosuke Okada; Tomoya Mita; Keiichi Torimoto; Satomi Wakasugi; Naoto Katakami; Hidenori Yoshii; Kohei Uryu; Keiko Nishida; Tadashi Arao; Yoshiya Tanaka; Masahiko Gosho; Iichiro Shimomura; Hirotaka Watada
Diabetes, obesity & metabolism, Jan. 2022

Glucose consumption of vascular cell types in culture: toward optimization of experimental conditions.
Keiichi Torimoto; Keisuke Okuno; Ryohei Kuroda; No'Ad Shanas; Stephanie M Cicalese; Kunie Eguchi; Katherine J Elliott; Tatsuo Kawai; Cali B Corbett; Amanda M Peluzzo; Amanda K St Paul; Michael V Autieri; Rosario Scalia; Victor Rizzo; Tomoki Hashimoto; Satoru Eguchi
American journal of physiology. Cell physiology, Jan. 2022

[A Case of Reactive Hypoglycemia Exacerbated Before Menstruation Improved by the Use of Continuous Glucose Monitoring].
Momo Saito; Yosuke Okada; Keiichi Torimoto; Yoshiya Tanaka
Journal of UOEH, 2022

Mitochondrial Telomerase Reverse Transcriptase, a Target for Cardiovascular Disease?
Keiichi Torimoto; Satoru Eguchi
Function (Oxford, England), 2022

Angiotensin II inhibition: a potential treatment to slow the progression of sarcopenia.
Jeffrey Kingsley; Keiichi Torimoto; Tomoki Hashimoto; Satoru Eguchi
Clinical science (London, England : 1979), Nov. 2021

Pathological role of activated mTOR in CXCR3+ memory B cells of rheumatoid arthritis.
Shigeru Iwata; Mingzeng Zhang; Maiko Hajime; Naoaki Ohkubo; Koshiro Sonomoto; Keiichi Torimoto; Yukihiro Kitanaga; Gulzhan Trimova; Yasuyuki Todoroki; Hiroko Miyata; Masanobu Ueno; Atsushi Nagayasu; Ryuichiro Kanda; Kazuhisa Nakano; Shingo Nakayamada; Kei Sakata; Yoshiya Tanaka
Rheumatology (Oxford, England), Nov. 2021

The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus.
Naoto Katakami; Tomoya Mita; Hidenori Yoshii; Toshihiko Shiraiwa; Tetsuyuki Yasuda; Yosuke Okada; Keiichi Torimoto; Yutaka Umayahara; Hideaki Kaneto; Takeshi Osonoi; Tsunehiko Yamamoto; Nobuichi Kuribayashi; Kazuhisa Maeda; Hiroki Yokoyama; Keisuke Kosugi; Kentaro Ohtoshi; Isao Hayashi; Satoru Sumitani; Mamiko Tsugawa; Kayoko Ryomoto; Hideki Taki; Tadashi Nakamura; Satoshi Kawashima; Yasunori Sato; Hirotaka Watada; Iichiro Shimomura
Diabetes therapy : research, treatment and education of diabetes and related disorders, Sep. 2021

Soluble (pro)renin receptor: a novel ligand for angiotensin II type 1 receptor?
Keiichi Torimoto; Satoru Eguchi
Clinical science (London, England : 1979), Jul. 2021

Relationship between glycemic intraday variations evaluated in continuous glucose monitoring and HbA1c variability in type 2 diabetes: pilot study.
Akemi Tokutsu; Yosuke Okada; Keiichi Torimoto; Yoshiya Tanaka
Diabetology & metabolic syndrome, Apr. 2021

Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes.
Satomi Wakasugi; Tomoya Mita; Naoto Katakami; Yosuke Okada; Hidenori Yoshii; Takeshi Osonoi; Keiko Nishida; Toshihiko Shiraiwa; Keiichi Torimoto; Akira Kurozumi; Masahiko Gosho; Iichiro Shimomura; Hirotaka Watada
BMJ open diabetes research & care, Apr. 2021

Enlarged glycemic variability in sulfonylurea-treated well-controlled type 2 diabetics identified using continuous glucose monitoring.
Fumi Uemura; Yosuke Okada; Keiichi Torimoto; Yoshiya Tanaka
Scientific reports, Mar. 2021

Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial.
Naoto Katakami; Tomoya Mita; Hidenori Yoshii; Toshihiko Shiraiwa; Tetsuyuki Yasuda; Yosuke Okada; Keiichi Torimoto; Yutaka Umayahara; Hideaki Kaneto; Takeshi Osonoi; Tsunehiko Yamamoto; Nobuichi Kuribayashi; Kazuhisa Maeda; Hiroki Yokoyama; Keisuke Kosugi; Kentaro Ohtoshi; Isao Hayashi; Satoru Sumitani; Mamiko Tsugawa; Kayoko Ryomoto; Hideki Taki; Tadashi Nakamura; Satoshi Kawashima; Yasunori Sato; Hirotaka Watada; Iichiro Shimomura
Cardiovascular diabetology, Jan. 2021

Work Environment-related Stress Factors are Correlated with Diabetes Development in Workers with Impaired Glucose Tolerance: A 5-year Follow-up Study Using the Brief Job Stress Questionnaire (BJSQ).
Motoko Sugito; Yosuke Okada; Keiichi Torimoto; Kazuhiko Enta; Yoshiya Tanaka
Journal of UOEH, 2021

Hyperparathyroidism Which Developed after Resection of a Fibroblast Growth Factor 23-producing Tumor.
Kenji Koikawa; Yosuke Okada; Keiichi Torimoto; Yoshiya Tanaka
Internal medicine (Tokyo, Japan), Oct. 2020

Changes in endothelial function during educational hospitalization and the contributor to improvement of endothelial function in type 2 diabetes mellitus.
Yukiko Goshima; Yosuke Okada; Keiichi Torimoto; Yoshihisa Fujino; Yoshiya Tanaka
Scientific reports, Sep. 2020

Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study.
Naoto Katakami; Tomoya Mita; Hidenori Yoshii; Toshihiko Shiraiwa; Tetsuyuki Yasuda; Yosuke Okada; Keiichi Torimoto; Yutaka Umayahara; Hideaki Kaneto; Takeshi Osonoi; Tsunehiko Yamamoto; Nobuichi Kuribayashi; Kazuhisa Maeda; Hiroki Yokoyama; Keisuke Kosugi; Kentaro Ohtoshi; Isao Hayashi; Satoru Sumitani; Mamiko Tsugawa; Kayoko Ryomoto; Hideki Taki; Tadashi Nakamura; Satoshi Kawashima; Yasunori Sato; Hirotaka Watada; Iichiro Shimomura
Cardiovascular diabetology, Jul. 2020

Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial.
Atsushi Tanaka; Michio Shimabukuro; Yosuke Okada; Kazuhiro Sugimoto; Akira Kurozumi; Keiichi Torimoto; Hiroyuki Hirai; Koichi Node
Cardiovascular diabetology, Jun. 2020

Usefulness of the index calculated as the product of levels of fasting plasma glucose and hemoglobin A1c for insulinoma screening.
Keiichi Torimoto; Yosuke Okada; Yoshiya Tanaka; Atsuko Matsuoka; Yushi Hirota; Wataru Ogawa; Yoshifumi Saisho; Isao Kurihara; Hiroshi Itoh; Shinya Inada; Masafumi Koga
Endocrine journal, May 2020

Response of thyrotropin-secreting pituitary tumors to preoperative lanreotide therapy. Report of two cases.
Akemi Tokutsu; Yosuke Okada; Keiichi Torimoto; Takashi Otsuka; Manabu Narisawa; Akira Kurozumi; Yoshiya Tanaka
Neuro endocrinology letters, Apr. 2020

Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study.
Akemi Tokutsu; Yosuke Okada; Keiichi Torimoto; Yoshiya Tanaka
Diabetology & metabolic syndrome, 2020

Correlations Between Glycemic Parameters Obtained from Continuous Glucose Monitoring and Hemoglobin A1c and Glycoalbumin Levels in Type 2 Diabetes Mellitus.
Satomi Sonoda; Yosuke Okada; Keiichi Torimoto; Kei Sugai; Fumi Uemura; Kenichi Tanaka; Maiko Hajime; Hiroko Mori; Yoshiya Tanaka
Journal of UOEH, 2020

Protocol of a Prospective Observational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes.
Tomoya Mita; Naoto Katakami; Yosuke Okada; Hidenori Yoshii; Takeshi Osonoi; Keiko Nishida; Toshihiko Shiraiwa; Keiichi Torimoto; Akira Kurozumi; Satomi Wakasugi; Masahiko Gosho; Iichiro Shimomura; Hirotaka Watada
Diabetes therapy : research, treatment and education of diabetes and related disorders, Oct. 2019

Addition of canagliflozin to insulin improves glycaemic control and reduces insulin dose in patients with type 2 diabetes mellitus: A randomized controlled trial.
Keiichi Torimoto; Yosuke Okada; Yukiko Goshima; Akemi Tokutsu; Yasunori Sato; Yoshiya Tanaka
Diabetes, obesity & metabolism, Sep. 2019

Efficacy and Safety of Tofogliflozin on 24-h Glucose Profile Based on Continuous Glucose Monitoring: Crossover Study of Sodium-Glucose Cotransporter 2 Inhibitor.
Akira Kurozumi; Yosuke Okada; Mototsugu Shimokawa; Yukiko Goshima; Takashi Otsuka; Manabu Narisawa; Keiichi Torimoto; Yoshiya Tanaka
Diabetes technology & therapeutics, Jul. 2019

Addition of Canagliflozin to Insulin Improves Glycemic Control and Reduces Insulin Dose in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose Monitoring
Keiichi Torimoto; Yosuke Okada; Yasunori Sato; Yoshiya Tanaka
DIABETES, Jun. 2019

Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus.
Keiichi Torimoto; Yosuke Okada; Yoshiya Tanaka
Diabetes therapy : research, treatment and education of diabetes and related disorders, Jun. 2019

Usefulness of hemoglobin A1c and glycated albumin measurements for insulinoma screening: an observational case-control study.
Keiichi Torimoto; Yosuke Okada; Yoshiya Tanaka; Atsuko Matsuoka; Yushi Hirota; Wataru Ogawa; Yoshifumi Saisho; Isao Kurihara; Hiroshi Itoh; Shinya Inada; Masafumi Koga
BMC cancer, Feb. 2019

Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring.
Maiko Hajime; Yosuke Okada; Hiroko Mori; Fumi Uemura; Satomi Sonoda; Kenichi Tanaka; Akira Kurozumi; Manabu Narisawa; Keiichi Torimoto; Yoshiya Tanaka
Diabetology & metabolic syndrome, 2019

Risk Factors for Hypoglycemic Coma: A Study of 33 Patients on Insulin Therapy Who Were Transported to the Hospital by Ambulance.
Takashi Otsuka; Yosuke Okada; Keiichi Torimoto; Yoshiya Tanaka
Internal medicine (Tokyo, Japan), Oct. 2018

Risk Factors of Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose Monitoring.
Keiichi Torimoto; Yosuke Okada; Maiko Hajime; Kenichi Tanaka; Yoshiya Tanaka
Diabetes technology & therapeutics, Sep. 2018

Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring.
Fumi Uemura; Yosuke Okada; Keiichi Torimoto; Yoshiya Tanaka
Diabetes technology & therapeutics, Feb. 2018

Twenty-four-hour variations in blood glucose level in Japanese type 2 diabetes patients based on continuous glucose monitoring.
Maiko Hajime; Yosuke Okada; Hiroko Mori; Takashi Otsuka; Mayuko Kawaguchi; Megumi Miyazaki; Fumi Kuno; Kei Sugai; Satomi Sonoda; Kenichi Tanaka; Akira Kurozumi; Manabu Narisawa; Keiichi Torimoto; Tadashi Arao; Yoshiya Tanaka
Journal of diabetes investigation, Jan. 2018

The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse Therapy.
Kenichi Tanaka; Yosuke Okada; Hiroko Mori; Keiichi Torimoto; Tadashi Arao; Yoshiya Tanaka
Internal medicine (Tokyo, Japan), Jan. 2018

Comparison of the Effects of Teneligliptin and Sitagliptin, Two Dipeptidyl Peptidase 4 Inhibitors with Different Half-Lives, on Glucose Fluctuation and Glucagon-Like Peptide-1 in Type 2 Diabetes Mellitus.
Akira Kurozumi; Yosuke Okada; Kei Sugai; Keiichi Torimoto; Yoshiya Tanaka
Journal of UOEH, 2018

Association Between Diabetic Microangiopathies and Glycemic Variability Assessed by Continuous Glucose Monitoring.
Satomi Sonoda; Yosuke Okada; Hiroko Mori; Fumi Uemura; Kei Sugai; Maiko Hajime; Kenichi Tanaka; Akira Kurozumi; Manabu Narisawa; Keiichi Torimoto; Yoshiya Tanaka
Journal of UOEH, 2018

Glycemic Profiling in Patients with Drug-Naïve Type 2 Diabetes by Continuous Glucose Monitoring.
Hiroko Mori; Yosuke Okada; Mayuko Kawaguchi; Takashi Otsuka; Megumi Miyazaki; Satomi Sonoda; Kei Sugai; Fumi Uemura; Kenichi Tanaka; Maiko Hajime; Akira Kurozumi; Manabu Narisawa; Keiichi Torimoto; Yoshiya Tanaka
Journal of UOEH, 2018

Anti-PD-1 Antibody Therapy Induces Hashimoto's Disease with an Increase in Peripheral Blood Follicular Helper T Cells.
Keiichi Torimoto; Yosuke Okada; Shingo Nakayamada; Satoshi Kubo; Yoshiya Tanaka
Thyroid : official journal of the American Thyroid Association, Oct. 2017

Determinants of hemoglobin A1c level in patients with type 2 diabetes after in-hospital diabetes education: A study based on continuous glucose monitoring.
Keiichi Torimoto; Yosuke Okada; Sachiko Sugino; Yoshiya Tanaka
Journal of diabetes investigation, May 2017

Comparative analysis of the effects of alogliptin and vildagliptin on glucose metabolism in type 2 diabetes mellitus.
Kenichi Tanaka; Yosuke Okada; Hiroko Mori; Megumi Miyazaki; Fumi Kuno; Satomi Sonoda; Kei Sugai; Maiko Hajime; Akira Kurozumi; Manabu Narisawa; Keiichi Torimoto; Tadashi Arao; Shinichiro Mine; Yoshiya Tanaka
Endocrine journal, Feb. 2017

Comparison Between Effectiveness of 100 mg/day Sitagliptin and a Switch to Mitiglinide Calcium Hydrate/Voglibose from 50 mg/day Sitagliptin in Patients with Type 2 Diabetes.
Tadashi Arao; Yosuke Okada; Keiichi Torimoto; Kei Sugai; Takashi Otsuka; Akira Kurozumi; Yoshiya Tanaka
Journal of UOEH, 2017

Clinical Features of Patients with Basedow's Disease and High Serum IgG4 Levels.
Keiichi Torimoto; Yosuke Okada; Akira Kurozumi; Manabu Narisawa; Tadashi Arao; Yoshiya Tanaka
Internal medicine (Tokyo, Japan), 2017

Early effects of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoring.
Keiichi Torimoto; Yosuke Okada; Kenji Koikawa; Yoshiya Tanaka
Diabetology & metabolic syndrome, 2017

Two Sisters with Graves' Disease and Similar Clinical Features who Tested Positive for Anti-insulin Antibodies after Thiamazole Treatment.
Keiichi Torimoto; Yosuke Okada; Hiroko Mori; Yoshiya Tanaka
Internal medicine (Tokyo, Japan), 2016

Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: a case report.
Akira Kurozumi; Yosuke Okada; Tadashi Arao; Yusuke Miyazaki; Maiko Yoshikawa; Keiichi Torimoto; Satoshi Kubo; Shingo Nakayamada; Yoshiya Tanaka
Endocrinology, diabetes & metabolism case reports, 2016

Prednisolone Dosing Regimen for Treatment of Subacute Thyroiditis.
Tadashi Arao; Yosuke Okada; Keiichi Torimoto; Akira Kurozumi; Manabu Narisawa; Sunao Yamamoto; Yoshiya Tanaka
Journal of UOEH, Jun. 2015

Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus.
Keiichi Torimoto; Yosuke Okada; Hiroko Mori; Takashi Otsuka; Mayuko Kawaguchi; Megumi Matsuda; Fumi Kuno; Kei Sugai; Satomi Sonoda; Maiko Hajime; Kenichi Tanaka; Tadashi Arao; Yoshiya Tanaka
Cardiovascular diabetology, Feb. 2015

Induction of thyroid remission using rituximab in a patient with type 3 autoimmune polyglandular syndrome including Graves' disease and type 1 diabetes mellitus: a case report.
Akira Kurozumi; Yosuke Okada; Tadashi Arao; Manabu Narisawa; Keiichi Torimoto; Sunao Yamamoto; Yoshiya Tanaka
Endocrine journal, 2015

Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes.
Keiichi Torimoto; Yosuke Okada; Hiroko Mori; Yoshiya Tanaka
Cardiovascular diabetology, Jun. 2014

Glucose variability before and after treatment of a patient with Graves' disease complicated by diabetes mellitus: assessment by continuous glucose monitoring.
Keiichi Torimoto; Yosuke Okada; Tadashi Arao; Hiroko Mori; Sunao Yamamoto; Manabu Narisawa; Akira Kurozumi; Yoshiya Tanaka
Endocrine journal, 2014

Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes.
Keiichi Torimoto; Yosuke Okada; Hiroko Mori; Maiko Hajime; Kenichi Tanaka; Akira Kurozumi; Manabu Narisawa; Sunao Yamamoto; Tadashi Arao; Hirofumi Matsuoka; Nobuo Inokuchi; Yoshiya Tanaka
Lipids in health and disease, Sep. 2013

Iatrogenic osteomalacia: report of two cases.
Sunao Yamamoto; Yosuke Okada; Hiroko Mori; Akira Kurozumi; Keiichi Torimoto; Tadashi Arao; Yoshiya Tanaka
Journal of UOEH, Mar. 2013

Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus.
Keiichi Torimoto; Yosuke Okada; Hiroko Mori; Yoshiya Tanaka
Cardiovascular diabetology, Jan. 2013

A case of zoledronate-induced tubulointerstitial nephritis with Fanconi syndrome.
Keiichi Torimoto; Yosuke Okada; Tadashi Arao; Hiroko Mori; Yoshiya Tanaka
Endocrine journal, 2012

【血糖変動評価で変わる新たな糖尿病治療】血糖変動からみた低血糖の問題点　血糖変動が小さい良質な血糖管理とは何か
鳥本 桂一, 岡田 洋右
Progress in Medicine, Mar. 2019, Reviewed, No invitation
Lead

心アミロイドーシスを合併した甲状腺アミロイドーシスによる粘液水腫性昏睡の1例
新生 忠司, 岡田 洋右, 鳥本 桂一, 瓜生 康平, 田中 良哉
内科, Feb. 2017, Reviewed, Null

胃切除術後の2型糖尿病症例における著明な血糖変動に対してCGMが有用であった1例
園田 里美, 岡田 洋右, 森 博子, 鳥本 桂一, 田中 良哉
内科, Jul. 2016, Null, Null

【SGLT2阻害薬の可能性〜これまで、そしてこれから〜】SGLT2阻害薬と血糖日内変動
鳥本 桂一, 岡田 洋右
月刊糖尿病, Dec. 2019, Reviewed, No invitation
Lead

血糖持続モニタリングを用いて月経前に増悪する反応性低血糖が改善した1例
齋藤桃, 岡田洋右, 鳥本桂一, 田中良哉
産業医科大学雑誌, Sep. 2022, Reviewed, No invitation

2型糖尿病と血管内皮機能障害
鳥本桂一, 岡田洋右, 田中良哉
産業医科大学雑誌, Apr. 2018, Reviewed, No invitation
Lead

Streptococcus agalactiaeによる両側腸腰筋膿瘍を呈した糖尿病の1例
大塚 隆史, 岡田 洋右, 鳥本 桂一, 稲田 良郁, 鈴鹿 佳南子, 瓜生 康平, 田中 良哉
糖尿病, Oct. 2019, Reviewed, No invitation

強化インスリン療法中2型糖尿病患者におけるCGMを用いた食後血糖値の評価
久能 芙美, 鳥本 桂一, 岡田 洋右, 須貝 慧, 園田 里美, 元 舞子, 田中 健一, 黒住 旭, 成澤 学, 山本 直, 森 博子, 新生 忠司, 田中 良哉
糖尿病, Sep. 2013, Reviewed, No invitation

糖尿病患者の歯周病罹患状況と保健行動に関しての現状調査
入江 めぐみ, 山下 美里, 田中 絵美, 森 博子, 鳥本 桂一, 元 舞子, 黒住 旭, 岡田 洋右, 田中 良哉
糖尿病, Oct. 2013, Reviewed, No invitation

ダンピング症候群症例におけるオーダーメイド治療　4症例のCGMを通して
園田 里美, 岡田 洋右, 森 博子, 元 舞子, 黒住 旭, 鳥本 桂一, 田中 良哉
糖尿病, Oct. 2013, Reviewed, No invitation

Usefulness of hemoglobin A1c and glycated albumin measurements for insulinoma screening: an observational case-control study.
Torimoto Keiichi, Okada Yosuke, Tanaka Yoshiya, Matsuoka Atsuko, Hirota Yushi, Ogawa Wataru, Saisho Yoshifumi, Kurihara Isao, Itoh Hiroshi, Inada Shinya, Koga Masafumi
BMC cancer, Feb. 2019, Reviewed, No invitation
Lead

Gilteritinib-Induced Hypopituitarism: A Case Report.
Hori Yuri, Okada Yosuke, Sonoda Satomi, Torimoto Keiichi, Tanaka Yoshiya
Cureus, Sep. 2024, Reviewed, No invitation

Risk Factor Analysis for Type 2 Diabetic Patients About Hypoglycemia Using Continuous Glucose Monitoring: Results from a Prospective Observational Study.
Uemura Fumi, Okada Yosuke, Mita Tomoya, Torimoto Keiichi, Wakasugi Satomi, Katakami Naoto, Yoshii Hidenori, Matsushita Koji, Nishida Keiko, Inokuchi Nobuo, Tanaka Yoshiya, Gosho Masahiko, Shimomura Iichiro, Watada Hirotaka
Diabetes technology & therapeutics, Feb. 2022, Reviewed, No invitation

Association Between Time in Range and Postprandial Glucose Contribution Rate in Non-Insulin-Treated Type 2 Diabetes Patients: Inverse Correlation of Time in Range with Postprandial Glucose Contribution Rate.
Uemura Fumi, Okada Yosuke, Torimoto Keiichi, Tanaka Yoshiya
Diabetes technology & therapeutics, Nov. 2022, Reviewed, No invitation

Efficacy and Safety of Tofogliflozin on 24-h Glucose Profile Based on Continuous Glucose Monitoring: Crossover Study of Sodium-Glucose Cotransporter 2 Inhibitor.
Kurozumi Akira, Okada Yosuke, Shimokawa Mototsugu, Goshima Yukiko, Otsuka Takashi, Narisawa Manabu, Torimoto Keiichi, Tanaka Yoshiya
Diabetes technology & therapeutics, Jun. 2019, Reviewed, No invitation

Risk Factors of Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose Monitoring.
Torimoto Keiichi, Okada Yosuke, Hajime Maiko, Tanaka Kenichi, Tanaka Yoshiya
Diabetes technology & therapeutics, Sep. 2018, Reviewed, No invitation
Lead

Risk factors of hypoglycaemia in patients with type 2 diabetes mellitus: A study based on continuous glucose monitoring.
Torimoto K,Okada Y,Hajime M,Tanaka K,Tanaka Y.
Diabetes technology & therapeutics, Apr. 2018, Reviewed, No invitation
Lead

Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus.
Torimoto Keiichi, Okada Yosuke, Tanaka Yoshiya
Diabetes therapy : research, treatment and education of diabetes and related disorders, Jun. 2019, Reviewed, No invitation
Lead

Relationship between blood glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics: Subanalysis of a prospective cohort study.
Tokutsu Akemi, Okada Yosuke, Mita Tomoya, Torimoto Keiichi, Wakasugi Satomi, Katakami Naoto, Yoshii Hidenori, Uryu Kohei, Nishida Keiko, Arao Tadashi, Tanaka Yoshiya, Gosho Masahiko, Shimomura Iichiro, Watada Hirotaka
Diabetes, obesity & metabolism, Jan. 2022, Reviewed, No invitation

Addition of canagliflozin to insulin improves glycaemic control and reduces insulin dose in patients with type 2 diabetes mellitus: A randomized controlled trial.
Torimoto Keiichi, Okada Yosuke, Goshima Yukiko, Tokutsu Akemi, Sato Yasunori, Tanaka Yoshiya
Diabetes, obesity & metabolism, Sep. 2019, Reviewed, No invitation
Lead

Relationship between glycemic intraday variations evaluated in continuous glucose monitoring and HbA1c variability in type 2 diabetes: pilot study.
Tokutsu Akemi, Okada Yosuke, Torimoto Keiichi, Tanaka Yoshiya
Diabetology & metabolic syndrome, Apr. 2021, Reviewed, No invitation

Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study.
Tokutsu Akemi, Okada Yosuke, Torimoto Keiichi, Tanaka Yoshiya
Diabetology & metabolic syndrome, Aug. 2020, Reviewed, No invitation

Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring.
Hajime Maiko, Okada Yosuke, Mori Hiroko, Uemura Fumi, Sonoda Satomi, Tanaka Kenichi, Kurozumi Akira, Narisawa Manabu, Torimoto Keiichi, Tanaka Yoshiya
Diabetology & metabolic syndrome, Feb. 2019, Reviewed, No invitation

Usefulness of the index calculated as the product of levels of fasting plasma glucose and hemoglobin A1c for insulinoma screening.
Torimoto Keiichi, Okada Yosuke, Tanaka Yoshiya, Matsuoka Atsuko, Hirota Yushi, Ogawa Wataru, Saisho Yoshifumi, Kurihara Isao, Itoh Hiroshi, Inada Shinya, Koga Masafumi
Endocrine journal, May 2020, Reviewed, No invitation
Lead

Comparative analysis of the effects of alogliptin and vildagliptin on glucose metabolism in type 2 diabetes mellitus.
Tanaka Kenichi, Okada Yosuke, Mori Hiroko, Miyazaki Megumi, Kuno Fumi, Sonoda Satomi, Sugai Kei, Hajime Maiko, Kurozumi Akira, Narisawa Manabu, Torimoto Keiichi, Arao Tadashi, Mine Shinichiro, Tanaka Yoshiya
Endocrine journal, Feb. 2017, Reviewed, Null

Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: a case report.
Kurozumi Akira, Okada Yosuke, Arao Tadashi, Miyazaki Yusuke, Yoshikawa Maiko, Torimoto Keiichi, Kubo Satoshi, Nakayamada Shingo, Tanaka Yoshiya
Endocrinology, diabetes & metabolism case reports, 2016, Null, Null

Hyperparathyroidism Which Developed after Resection of a Fibroblast Growth Factor 23-producing Tumor.
Koikawa Kenji, Okada Yosuke, Torimoto Keiichi, Tanaka Yoshiya
Internal medicine (Tokyo, Japan), Oct. 2020, Reviewed, No invitation

The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse Therapy.
Tanaka Kenichi, Okada Yosuke, Mori Hiroko, Torimoto Keiichi, Arao Tadashi, Tanaka Yoshiya
Internal medicine (Tokyo, Japan), Apr. 2018, Reviewed, Null

Two Sisters with Graves' Disease and Similar Clinical Features who Tested Positive for Anti-insulin Antibodies after Thiamazole Treatment.
Torimoto Keiichi, Okada Yosuke, Mori Hiroko, Tanaka Yoshiya
Internal medicine (Tokyo, Japan), 2016, Null, Null
Lead

Glycemic Profiling in Patients with Drug-Naïve Type 2 Diabetes by Continuous Glucose Monitoring
Mori H,Okada Y,Kawaguchi M,Otsuka T,Miyazaki M,Sonoda S,Sugai K,Uemura F, Tanaka K,Hajime M,Kurozumi A,Narisawa M,Torimoto K,Tanaka Y.
J UOEH, Apr. 2018, Reviewed, No invitation

Work Environment-related Stress Factors are Correlated with Diabetes Development in Workers with Impaired Glucose Tolerance: A 5-year Follow-up Study Using the Brief Job Stress Questionnaire (BJSQ).
Sugito Motoko, Okada Yosuke, Torimoto Keiichi, Enta Kazuhiko, Tanaka Yoshiya
Journal of UOEH, May 2021, Reviewed, No invitation

Correlations Between Glycemic Parameters Obtained from Continuous Glucose Monitoring and Hemoglobin A1c and Glycoalbumin Levels in Type 2 Diabetes Mellitus.
Sonoda Satomi, Okada Yosuke, Torimoto Keiichi, Sugai Kei, Uemura Fumi, Tanaka Kenichi, Hajime Maiko, Mori Hiroko, Tanaka Yoshiya
Journal of UOEH, Jul. 2020, Reviewed, No invitation

A Case of Marine-Lenhart Syndrome with Predominance of Plummer Disease.
Miyazaki Megumi, Okada Yosuke, Torimoto Keiichi, Tanaka Yoshiya
Journal of UOEH, Apr. 2019, Reviewed, No invitation

Comparison of the Effects of Teneligliptin and Sitagliptin, Two Dipeptidyl Peptidase 4 Inhibitors with Different Half-Lives, on Glucose Fluctuation and Glucagon-Like Peptide-1 in Type 2 Diabetes Mellitus.
Kurozumi Akira, Okada Yosuke, Sugai Kei, Torimoto Keiichi, Tanaka Yoshiya
Journal of UOEH, Apr. 2018, Reviewed, Null

Determinants of hemoglobin A1c level in patients with type 2 diabetes after in-hospital diabetes education: A study based on continuous glucose monitoring.
Torimoto Keiichi, Okada Yosuke, Sugino Sachiko, Tanaka Yoshiya
Journal of diabetes investigation, Oct. 2016, Reviewed, No invitation
Lead

Response of thyrotropin-secreting pituitary tumors to preoperative lanreotide therapy. Report of two cases.
Tokutsu Akemi, Okada Yosuke, Torimoto Keiichi, Otsuka Takashi, Narisawa Manabu, Kurozumi Akira, Tanaka Yoshiya
Neuro endocrinology letters, Apr. 2020, Reviewed, No invitation

An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus.
Sumikawa Maiko Hajime, Iwata Shigeru, Zhang Mingzeng, Miyata Hiroko, Ueno Masanobu, Todoroki Yasuyuki, Nagayasu Atsushi, Kanda Ryuichiro, Sonomoto Koshiro, Torimoto Keiichi, Lee Seunghyun, Nakayamada Shingo, Yamamoto Kazuo, Okada Yosuke, Tanaka Yoshiya
Rheumatology (Oxford, England), Nov. 2021, Reviewed, No invitation

Hypoglycemia induces vascular endothelial dysfunction in subjects with normal glucose tolerance.
Tanaka Kenichi, Okada Yosuke, Torimoto Keiichi, Nishio Kosuke, Narisawa Manabu, Tanaka Yoshiya
Scientific reports, Feb. 2022, Reviewed, No invitation

Comprehensive immunophenotypic analysis reveals the pathological involvement of Th17 cells in Graves' disease.
Torimoto Keiichi, Okada Yosuke, Nakayamada Shingo, Kubo Satoshi, Kurozumi Akira, Narisawa Manabu, Tanaka Yoshiya
Scientific reports, Oct. 2022, Reviewed, No invitation
Lead

Enlarged glycemic variability in sulfonylurea-treated well-controlled type 2 diabetics identified using continuous glucose monitoring.
Uemura Fumi, Okada Yosuke, Torimoto Keiichi, Tanaka Yoshiya
Scientific reports, Mar. 2021, Reviewed, No invitation

Changes in endothelial function during educational hospitalization and the contributor to improvement of endothelial function in type 2 diabetes mellitus.
Goshima Yukiko, Okada Yosuke, Torimoto Keiichi, Fujino Yoshihisa, Tanaka Yoshiya
Scientific reports, Sep. 2020, Reviewed, No invitation

Blood glucose dynamics during sleep in patients with obstructive sleep apnea and normal glucose tolerance: effects of CPAP therapy.
Saito Kimimasa, Okada Yosuke, Torimoto Keiichi, Takamatsu Yoko, Tanaka Yoshiya
Sleep & breathing = Schlaf & Atmung, Dec. 2021, Reviewed, No invitation

プランマー病の病勢が優位と考えられたマリン-レンハルト症候群の1例(A Case of Marine-Lenhart Syndrome with Predominance of Plummer Disease)
宮崎 恵, 岡田 洋右, 鳥本 桂一, 田中 良哉
産業医科大学雑誌, Jun. 2019, Reviewed, No invitation

Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial.
Tanaka Atsushi, Shimabukuro Michio, Okada Yosuke, Sugimoto Kazuhiro, Kurozumi Akira, Torimoto Keiichi, Hirai Hiroyuki, Node Koichi,
Cardiovascular diabetology, Jun. 2020, Null, Null